Stericycle (NASDAQ:SRCL) Releases FY 2024 Earnings Guidance

Stericycle (NASDAQ:SRCL) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 2.200-2.500 for the period, compared to the consensus estimate of 2.330. The company issued revenue guidance of -.

Stericycle Stock Down 0.4 %

SRCL traded down $0.20 during trading hours on Friday, hitting $46.31. The company’s stock had a trading volume of 802,028 shares, compared to its average volume of 414,517. Stericycle has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The company has a quick ratio of 0.94, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a 50-day simple moving average of $51.35 and a 200 day simple moving average of $48.17.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, beating the consensus estimate of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The firm had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. During the same period last year, the firm earned $0.49 EPS. The firm’s revenue was down 2.8% compared to the same quarter last year. As a group, equities research analysts expect that Stericycle will post 2.32 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on SRCL shares. StockNews.com cut Stericycle from a buy rating to a hold rating in a research report on Tuesday, April 2nd. Truist Financial increased their price target on Stericycle from $50.00 to $57.00 and gave the company a hold rating in a research note on Thursday, February 29th. Stifel Nicolaus increased their price target on Stericycle from $70.00 to $75.00 and gave the company a buy rating in a research note on Thursday, February 29th. Robert W. Baird decreased their price target on Stericycle from $62.00 to $55.00 and set a neutral rating for the company in a research note on Friday. Finally, Wells Fargo & Company increased their price target on Stericycle from $40.00 to $48.00 and gave the company an underweight rating in a research note on Friday, March 1st. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of Hold and a consensus target price of $60.80.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.